Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein

被引:53
|
作者
Dodart, JC
Mathis, C
Bales, KR
Paul, SM
Ungerer, A
机构
[1] Univ Strasbourg, Lab Ethol & Neurobiol, CNRS, UMR 1295, F-67000 Strasbourg, France
[2] Eli Lilly & Co, Lilly Res Labs, Div Neurosci, Indianapolis, IN 46285 USA
关键词
Alzheimer's disease; transgenic mice; C-14]2-deoxyglucose; beta-amyloid precursor protein; brain glucose metabolism;
D O I
10.1016/S0304-3940(99)00847-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the present study, we examined whether the relative levels of regional brain [C-14]2-deoxyglucose (2-DG) uptake are altered in a transgenic mouse model of Alzheimer's disease which overexpresses a mutated form of the human beta-amyloid precursor protein (mutation V717F). We show that the relative levels of 2-DG uptake are significantly reduced in the septum, thalamus, dentate gyrus and parietal cortex of 3-month-old transgenic mice as compared with wild-type littermates. In 10-month-old transgenic mice, these alterations also extend to the CA3 hippocampal region, the cingulate, retrosplenial, occipital and temporal cortices, suggesting an age-dependent decrease in the regional 2-DG uptake. These results suggest that expression of a mutated APP gene induces an early regional cerebral hypometabolism independently of amyloid deposition per se. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 50 条
  • [41] Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study
    Iulita, M. Florencia
    Allard, Simon
    Richter, Luise
    Munter, Lisa-Marie
    Ducatenzeiler, Adriana
    Weise, Christoph
    Do Carmo, Sonia
    Klein, William L.
    Multhaup, Gerhard
    Cuello, A. Claudio
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [42] Neurodegeneration and gliosis in transgenic mice overexpressing a carboxy-terminal fragment of Alzheimer amyloid-beta protein precursor
    Sato, M
    Kawarabayashi, T
    Shoji, M
    Kobayashi, T
    Tada, N
    Matsubara, E
    Hirai, S
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (05) : 296 - 307
  • [43] Early Endosomal Abnormalities and Cholinergic Neuron Degeneration in Amyloid-β Protein Precursor Transgenic Mice
    Choi, Jennifer H. K.
    Kaur, Gurjinder
    Mazzella, Matthew J.
    Morales-Corraliza, Jose
    Levy, Efrat
    Mathews, Paul M.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (03) : 691 - 700
  • [44] Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
    Moechars, D
    Dewachter, I
    Lorent, K
    Reverse, D
    Baekelandt, V
    Naidu, A
    Tesseur, I
    Spittaels, K
    Van Den Haute, C
    Checler, F
    Godaux, E
    Cordell, B
    Van Leuven, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6483 - 6492
  • [45] Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor
    Davis, J
    Xu, F
    Deane, R
    Romanov, G
    Previti, ML
    Zeigler, K
    Zlokovic, BV
    Van Nostrand, WE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20296 - 20306
  • [46] AGE-RELATED CNS DISORDER AND EARLY DEATH IN TRANSGENIC FVB/N MICE OVEREXPRESSING ALZHEIMER AMYLOID PRECURSOR PROTEINS
    HSIAO, KK
    BORCHELT, DR
    OLSON, K
    JOHANNSDOTTIR, R
    KITT, C
    YUNIS, W
    XU, S
    ECKMAN, C
    YOUNKIN, S
    PRICE, D
    IADECOLA, C
    CLARK, HB
    CARLSON, G
    NEURON, 1995, 15 (05) : 1203 - 1218
  • [47] Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid β precursor protein
    Miao, J
    Xu, F
    Davis, J
    Otte-Höller, I
    Verbeek, MM
    Van Nostrand, WE
    AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (02): : 505 - 515
  • [48] Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice
    Dewachter, I
    Reversé, D
    Caluwaerts, N
    Ris, L
    Kuipéri, C
    Van den Haute, C
    Spittaels, K
    Umans, L
    Serneels, L
    Thiry, E
    Moechars, D
    Mercken, M
    Godaux, E
    Van Leuven, F
    JOURNAL OF NEUROSCIENCE, 2002, 22 (09): : 3445 - 3453
  • [49] Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
    Murrell, JR
    Hake, AM
    Quaid, KA
    Farlow, MR
    Ghetti, B
    ARCHIVES OF NEUROLOGY, 2000, 57 (06) : 885 - 887
  • [50] Amyloid-β Contributes to Blood-Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
    Hartz, Anika M. S.
    Bauer, Bjoern
    Soldner, Emma L. B.
    Wolf, Andrea
    Boy, Sandra
    Backhaus, Roland
    Mihaljevic, Ivan
    Bogdahn, Ulrich
    Kluenemann, Hans H.
    Schuierer, Gerhard
    Schlachetzki, Felix
    STROKE, 2012, 43 (02) : 514 - 523